These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
381 related articles for article (PubMed ID: 20407454)
21. An uncertain future for cardiovascular drug development? Garber AM N Engl J Med; 2009 Mar; 360(12):1169-71. PubMed ID: 19297568 [No Abstract] [Full Text] [Related]
22. A new era of hope for the world's most neglected diseases. The PLoS Med; 2005 Sep; 2(9):e323. PubMed ID: 16138790 [TBL] [Abstract][Full Text] [Related]
23. New IGF drug stirs competition in growth factor segment. Ratner M Nat Biotechnol; 2005 Oct; 23(10):1192. PubMed ID: 16211044 [No Abstract] [Full Text] [Related]
24. Can open-source drug R&D repower pharmaceutical innovation? Munos B Clin Pharmacol Ther; 2010 May; 87(5):534-6. PubMed ID: 20407458 [TBL] [Abstract][Full Text] [Related]
25. Open innovation: share or die.. Talaga P Drug Discov Today; 2009 Nov; 14(21-22):1003-5. PubMed ID: 19778629 [No Abstract] [Full Text] [Related]
26. Overcoming the obstacles in the pharma/biotech industry: 2008 update. Graul AI; Revel L; Rosa E; Cruces E Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298 [TBL] [Abstract][Full Text] [Related]
27. The people vs patents. New Sci; 2002 Jul; 175(2351):3. PubMed ID: 12625337 [No Abstract] [Full Text] [Related]
28. US drug manufacturers set up joint testing group. Davies E BMJ; 2012 Sep; 345():e6394. PubMed ID: 23002149 [No Abstract] [Full Text] [Related]
29. Opinion: anticipating change in drug development: the emerging era of translational medicine and therapeutics. Fitzgerald GA Nat Rev Drug Discov; 2005 Oct; 4(10):815-8. PubMed ID: 16224453 [TBL] [Abstract][Full Text] [Related]
30. Showcasing bioscience in Rhode Island. Spero D R I Med J (2013); 2013 Feb; 96(2):15. PubMed ID: 23641419 [TBL] [Abstract][Full Text] [Related]
31. Indian generics companies go on spending spree. Jayaraman KS Nat Rev Drug Discov; 2005 Aug; 4(8):616-7. PubMed ID: 16106583 [No Abstract] [Full Text] [Related]
32. Competitive collaboration in the pharmaceutical and biotechnology industry. Bingham A; Ekins S Drug Discov Today; 2009 Dec; 14(23-24):1079-81. PubMed ID: 19835979 [No Abstract] [Full Text] [Related]
33. The economics of drug development: a grim reality and a role for clinical pharmacology. Honig P; Lalonde R Clin Pharmacol Ther; 2010 Mar; 87(3):247-51. PubMed ID: 20160740 [No Abstract] [Full Text] [Related]
34. Medicine and the pharmaceutical industry. Baxter P Dev Med Child Neurol; 2006 Aug; 48(8):627. PubMed ID: 16836771 [No Abstract] [Full Text] [Related]
35. Ask the experts: future of the pharmaceutical industry. Interview by Future Medicinal Chemistry. Cottens S; Eaton M; Fuhr J; Geary S; Johnson DS; Li G; Raveglia L; Robertson GM; Westwell A Future Med Chem; 2011 Nov; 3(15):1863-72. PubMed ID: 22023030 [TBL] [Abstract][Full Text] [Related]
36. Pharmaceutical research and development: what do we get for all that money? Light DW; Lexchin JR BMJ; 2012 Aug; 345():e4348. PubMed ID: 22872694 [No Abstract] [Full Text] [Related]
37. The 10 x '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020. Infectious Diseases Society of America Clin Infect Dis; 2010 Apr; 50(8):1081-3. PubMed ID: 20214473 [TBL] [Abstract][Full Text] [Related]
38. Global pharmacogenomics: where is the research taking us? Olivier C; Williams-Jones B Glob Public Health; 2014; 9(3):312-24. PubMed ID: 24580118 [TBL] [Abstract][Full Text] [Related]